newsfilter
← Latest News
Business Wire·

Pear Therapeutics Announces New 12-Month Analysis Showing Reduction in Healthcare Resource Utilization and Associated Costs in Patients Treated with reSET-O®

reSET-O® is the only FDA-authorized prescription digital therapeutic (PDT) for the treatment of opioid use disorder (OUD) Results support the real-world value of reSET-O, demonstrating durable treatment outcomes and reductions in healthcare resou